Carol L. Delaney - Concepedia

Author

Carol L. Delaney

Also Known As

C. L. DELANEY, C. L. Delaney, C.L. Delaney, Carol L Delaney, Carol L. Delaney, Carol Lowery Delaney, Yanagisako, Sylvia Junko 1945-

Publications

904

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

Carol L. Delaney is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	493
2	Biochemistry	4	4	137
3	Natural Sciences	3	3	120
4	Biomolecular Engineering	1	1	11
5	Chemical Biology	1	1	34

Carol L. Delaney

Publications

598

Citations

H-Index

Page 1

	Year	Citations
Venous smooth muscle contains vasoconstrictor ETB-like receptors Suzanne Moreland, Diane M. McMullen, Carol L. Delaney, Biochemical and Biophysical Research Communications Venous DiseaseMolecular PhysiologyEtb-like ReceptorsMedicineVascular Pharmacology	1992	256
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships Kyoung Soon Kim, Ligang Qian, J. Eileen Bird, Journal of Medicinal Chemistry Medicinal ChemistryNovel Quinoxaline HeterocyclePharmacological StudyBiochemistryVs 30	1993	70
Omapatrilat Versus Lisinopril Vito M. Campese, Kenneth C. Lasseter, Carlos M. Ferrario, Hypertension	2001	59
The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta Maria L. Webb, Kenneth E.J. Dickinson, Carol L. Delaney, Biochemical and Biophysical Research Communications HypertensionCardiovascular DiseaseMedicineVascular PharmacologyPhysiology	1992	56
BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174 Kenneth E.J. Dickinson, Robert Cohen, S. Skwish, British Journal of Pharmacology	1994	36
Dihydropyrimidine angiotensin II receptor antagonists Karnail S. Atwal, Syed Z. Ahmed, J. Eileen Bird, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryReceptor Antagonist LosartanBiochemistryMedicine	1992	34
Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists Harold N. Weller, Arthur V. Miller, Robert V. Moquin, Bioorganic & Medicinal Chemistry Letters Benzothiadiazine DioxidesMolecular PharmacologyMedicinePhysiologyCardiovascular Pharmacology	1992	18
Synthesis, Biological Properties, and Structure-Activity Relationships of Quinoxaline Angiotensin II Receptor Antagonists Kyoung Soon Kim, Ligang Qian, Kennet E.J. Dickinson, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionStructure-activity Relationships	1993	17
Synthesis of N-Alkyl-1,2,4-oxadiazinones as Angiotensin-II (AT1) Receptor Antagonists Harold N. Weller, Arthur V. Miller, Kenneth E.J. Dickinson, Heterocycles Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryHeterocyclicBiochemistry	1993	16
Quinoline-4-carboxylic acids as angiotensin II receptor antagonists John Lloyd, Denis E. Ryono, J. Eileen Bird, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinePhysiologyPharmacological AgentQuinoline-4-carboxylic Acids	1994	15

Page 1